<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Research Services Division</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/FBD43890-08B8-4CE0-A3BC-DABB620D95BB"><gtr:id>FBD43890-08B8-4CE0-A3BC-DABB620D95BB</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Gay</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7AF16F9F-FD6A-49B4-A729-26A6FAEE95E3"><gtr:id>7AF16F9F-FD6A-49B4-A729-26A6FAEE95E3</gtr:id><gtr:firstName>Douglas</gtr:firstName><gtr:otherNames>Thomas</gtr:otherNames><gtr:surname>Fearon</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/877C0FAD-13BC-4F15-A199-F32B4E46D637"><gtr:id>877C0FAD-13BC-4F15-A199-F32B4E46D637</gtr:id><gtr:firstName>Tom</gtr:firstName><gtr:surname>Blundell</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0400007"><gtr:id>CF10AEF5-0D60-4E7D-A23A-709F6B2755E5</gtr:id><gtr:title>Structure and function of the Toll-like receptor signalling pathways: key regulators of immune responses.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0400007</gtr:grantReference><gtr:abstractText>We plan to publicise important outcomes in consultation with the University of Cambridge press office (see http://www.admin.cam.ac.uk/offices/press/intro.html)</gtr:abstractText><gtr:technicalSummary>The human Toll-like receptors (hTlrs) are at the frontline of immune defence against bacterial and viral pathogens. They are located on the surface of leucocytes and recognise conserved pathogen associated molecular patterns such as lipopolysaccharides. In response to these stimuli, the hTlrs mediate a signal transduction pathway that leads to the activation of the transcription factors NF?B and interferon response factor 3. This leads to expression of pro-inflammatory cytokines such as tumour necrosis factor and interleukin 1, anti-viral and co-stimulatory molecules. This innate immune response is closely coupled to the development of adaptive immunity and both are required for an effective anti-microbial responses in vertebrates. As hTlrs regulate the production of pro-inflammatory cytokines they are also implicated in important inflammatory diseases such as endotoxin shock and rheumatoid arthritis. In this proposal we seek to understand the signal transduction pathways mediated through hTlrs at a molecular and structural level. We aim to address three key questions in the field. Firstly, how do the extracellular domains of the hTlrs recognise pathogen patterns and how is this molecular recognition linked to signal transduction? Secondly, what is the structure and function of the cytosolic complex that forms in response to receptor activation and how is the downstream signalling pathway regulated? Thirdly, can small molecules that trigger innate immunity such as imidazoquinolines be exploited to break tolerance and induce adaptive immune responses to tumours?</gtr:technicalSummary><gtr:fund><gtr:end>2010-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>950000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Equipment Grant</gtr:description><gtr:end>2008-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>AF9FCAF0-7A1E-4B00-AB2B-936CC753DBBD</gtr:id><gtr:outcomeId>B438F89ECEF0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>11000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>International Joint Project</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>016ACD69-3BB6-4818-94B7-B70509CC011D</gtr:id><gtr:outcomeId>89BCA39547E0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1600000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Project Grant</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>CHDI Foundation</gtr:fundingOrg><gtr:id>FF5CF070-B351-4B82-947D-5DE643CF1068</gtr:id><gtr:outcomeId>CADF77E261C0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Programme Grant (Structure, mechanism and regulation of Toll receptor membrane complexes)</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>D2E2D38B-338D-41C1-A332-74A91E893A30</gtr:id><gtr:outcomeId>E20358D301A0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Methods for quantifying signalling</gtr:description><gtr:id>D2FE26F4-6998-4391-BD06-7CF1D4F4F4DC</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>2BB2B6552ED</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Signalling assays</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>65CF8AA1-9D5A-4640-98AC-E7469908C04D</gtr:id><gtr:title>A TIR domain variant of MyD88 adapter-like (Mal)/TIRAP results in loss of MyD88 binding and reduced TLR2/TLR4 signaling.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16c9d853ef36f7106631c349894b125d"><gtr:id>16c9d853ef36f7106631c349894b125d</gtr:id><gtr:otherNames>Nagpal K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>75E09CC0E2D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DA56F8C-8C23-4072-BC41-DF3729E8C806</gtr:id><gtr:title>Sensing of Gram-positive bacteria in Drosophila: GNBP1 is needed to process and present peptidoglycan to PGRP-SA.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4fb28c7b7f759ed5da54d4f587d639a"><gtr:id>c4fb28c7b7f759ed5da54d4f587d639a</gtr:id><gtr:otherNames>Wang L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>154B21D8EB1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F09EA4E6-2EB1-423A-AE5E-BC6B69450CBF</gtr:id><gtr:title>Toll-like receptors as molecular switches.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7af28f06edb07f35fdd2d1d85b73704"><gtr:id>a7af28f06edb07f35fdd2d1d85b73704</gtr:id><gtr:otherNames>Gay NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>79682B30F6D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40D266D1-3F2E-43A4-B84E-90C2C51019F5</gtr:id><gtr:title>Peptidoglycan recognition protein-SD provides versatility of receptor formation in Drosophila immunity.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4fb28c7b7f759ed5da54d4f587d639a"><gtr:id>c4fb28c7b7f759ed5da54d4f587d639a</gtr:id><gtr:otherNames>Wang L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>866E4609FE0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>060EAB29-0642-477D-89D3-8C0424D0D71A</gtr:id><gtr:title>A dimer of the Toll-like receptor 4 cytoplasmic domain provides a specific scaffold for the recruitment of signalling adaptor proteins.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35802cf40845b7f5723d894c28ef3d22"><gtr:id>35802cf40845b7f5723d894c28ef3d22</gtr:id><gtr:otherNames>N??ez Miguel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>8E4646A44F6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EA21EFF-C225-42C6-BD66-24FA367EAD34</gtr:id><gtr:title>Assembly of oligomeric death domain complexes during Toll receptor signaling.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5297648d9f7c1a4f578f5aebca5f1f6"><gtr:id>b5297648d9f7c1a4f578f5aebca5f1f6</gtr:id><gtr:otherNames>Moncrieffe MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>1108B00F732</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01F9BFFB-291A-4DB5-900A-48A175C1EE4B</gtr:id><gtr:title>Conserved mechanisms of signal transduction by Toll and Toll-like receptors.</gtr:title><gtr:parentPublicationTitle>Journal of endotoxin research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ff98c72898a01ac75c133f78b4e23cf"><gtr:id>9ff98c72898a01ac75c133f78b4e23cf</gtr:id><gtr:otherNames>Gangloff M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0968-0519</gtr:issn><gtr:outcomeId>FB4ACD2AD19</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4478EC66-EA5F-43B7-A599-262C5BD640C8</gtr:id><gtr:title>An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55def6e19457a0e5921289f3119168f1"><gtr:id>55def6e19457a0e5921289f3119168f1</gtr:id><gtr:otherNames>Motshwene PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>89AB8ACEA29</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE93BB65-38F4-4534-8506-F3A7AEB3812F</gtr:id><gtr:title>The molecular basis of the host response to lipopolysaccharide.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc38ddc2aa13707bc8b3e3c7d2d3829c"><gtr:id>dc38ddc2aa13707bc8b3e3c7d2d3829c</gtr:id><gtr:otherNames>Bryant CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1740-1526</gtr:issn><gtr:outcomeId>A088ED592C1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9963F05-9A8E-4316-B63A-AD8E95138D10</gtr:id><gtr:title>Bioinformatic analysis of Toll-like receptor sequences and structures.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bdbcc6c899882f237eac5d622f63da8"><gtr:id>2bdbcc6c899882f237eac5d622f63da8</gtr:id><gtr:otherNames>Monie TP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>76A7C16F9B9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CB94EC8-089E-4DD1-BA10-400E316FDBC9</gtr:id><gtr:title>Conserved features in the extracellular domain of human toll-like receptor 8 are essential for pH-dependent signaling.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/991185143b0742bc16b67df53ce80c7b"><gtr:id>991185143b0742bc16b67df53ce80c7b</gtr:id><gtr:otherNames>Gibbard RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>4ACD2C52F1F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>814B21C3-A655-4BE4-BAB6-F505E09382F8</gtr:id><gtr:title>The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d72101a36c91172d40e63d2015f96c24"><gtr:id>d72101a36c91172d40e63d2015f96c24</gtr:id><gtr:otherNames>Rowe DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>34201279B61</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>417B214C-0237-4B61-9E98-2214252897DF</gtr:id><gtr:title>Structural insight into the mechanism of activation of the Toll receptor by the dimeric ligand Sp&amp;auml;tzle.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ff98c72898a01ac75c133f78b4e23cf"><gtr:id>9ff98c72898a01ac75c133f78b4e23cf</gtr:id><gtr:otherNames>Gangloff M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>5B86071F1E5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3C559DE-FAE2-4AFC-B8C9-78FF13C2F83E</gtr:id><gtr:title>Role of the Spatzle Pro-domain in the generation of an active toll receptor ligand.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a76f77a2758d5c1e8a1193ab3b8df478"><gtr:id>a76f77a2758d5c1e8a1193ab3b8df478</gtr:id><gtr:otherNames>Weber AN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>7DEEF9C088A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90E08F41-6004-41FF-B4A3-F7DBCB8EF686</gtr:id><gtr:title>Elucidation of the MD-2/TLR4 interface required for signaling by lipid IVa.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70b93ce1240a36e8bf072ecb566842f1"><gtr:id>70b93ce1240a36e8bf072ecb566842f1</gtr:id><gtr:otherNames>Walsh C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>20441A3BC63</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48B05D37-BC7B-4290-9D16-21C95E4C7E89</gtr:id><gtr:title>Activating immunity: lessons from the TLRs and NLRs.</gtr:title><gtr:parentPublicationTitle>Trends in biochemical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bdbcc6c899882f237eac5d622f63da8"><gtr:id>2bdbcc6c899882f237eac5d622f63da8</gtr:id><gtr:otherNames>Monie TP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0968-0004</gtr:issn><gtr:outcomeId>061B68E8352</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05ABCB95-29B6-4336-84F7-53B177906F6F</gtr:id><gtr:title>Trif-related adapter molecule is phosphorylated by PKC{epsilon} during Toll-like receptor 4 signaling.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88af4d55620269caaa68385e78cb95cb"><gtr:id>88af4d55620269caaa68385e78cb95cb</gtr:id><gtr:otherNames>McGettrick AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>27DA5BB3E21</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F68116DA-EB97-4EF3-BA04-1E51223E1719</gtr:id><gtr:title>Structure and regulation of cytoplasmic adapter proteins involved in innate immune signaling.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bdbcc6c899882f237eac5d622f63da8"><gtr:id>2bdbcc6c899882f237eac5d622f63da8</gtr:id><gtr:otherNames>Monie TP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn><gtr:outcomeId>2B55AB5DDC6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>375514BC-E4E6-42CD-9BE3-A32DE8502263</gtr:id><gtr:title>MD-2: the Toll 'gatekeeper' in endotoxin signalling.</gtr:title><gtr:parentPublicationTitle>Trends in biochemical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ff98c72898a01ac75c133f78b4e23cf"><gtr:id>9ff98c72898a01ac75c133f78b4e23cf</gtr:id><gtr:otherNames>Gangloff M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0968-0004</gtr:issn><gtr:outcomeId>A1319044CAF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34EC5C9B-4500-4A91-A597-DEDA7665E57E</gtr:id><gtr:title>Structure and function of Toll receptors and their ligands.</gtr:title><gtr:parentPublicationTitle>Annual review of biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7af28f06edb07f35fdd2d1d85b73704"><gtr:id>a7af28f06edb07f35fdd2d1d85b73704</gtr:id><gtr:otherNames>Gay NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0066-4154</gtr:issn><gtr:outcomeId>86A4C1E9683</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8ADE77A4-1ED2-4028-AA18-64893BF8933C</gtr:id><gtr:title>Activation of insect and vertebrate toll signaling: from endogenous cytokine ligand to direct recognition of pathogen patterns.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7af28f06edb07f35fdd2d1d85b73704"><gtr:id>a7af28f06edb07f35fdd2d1d85b73704</gtr:id><gtr:otherNames>Gay NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0065-2598</gtr:issn><gtr:outcomeId>FB3C35C9B5A</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0400007</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>